Global General Influenza Diagnostics Market Insights, Forecast to 2028

Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.
Market Analysis and Insights: Global General Influenza Diagnostics Market
The global General Influenza Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, RIDT accounting for % of the General Influenza Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China General Influenza Diagnostics market size is valued at US$ million in 2021, while the North America and Europe General Influenza Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe General Influenza Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global General Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global General Influenza Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global General Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global General Influenza Diagnostics market.
Global General Influenza Diagnostics Scope and Market Size
General Influenza Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global General Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
RIDT
Viral Culture
DFA
Serological Assays
Segment by Application
Hospitals
Clinical Laboratories
Other End-User
By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA